Previous issues
-
Previous issues
Volume 26(4) Oct 2020
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Reviews Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
- Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
- Clin Mol Hepatol. 2020;26(4):383-400.
- Liver graft from donation after circulatory death donor: Real practice to improve graft viability
- Koji Hashimoto
- Clin Mol Hepatol. 2020;26(4):401-410.
- Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
- Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
- Clin Mol Hepatol. 2020;26(4):411-429.
- Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
- Kyung-Soo Kim, Byung-Wan Lee
- Clin Mol Hepatol. 2020;26(4):430-443.
- Managing liver cirrhotic complications: Overview of esophageal and gastric varices
- Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
- Clin Mol Hepatol. 2020;26(4):444-460.
- Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2020;26(4):461-475.
- Editorials Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
- Sooyeon Oh, Jooho Lee
- Clin Mol Hepatol. 2020;26(4):476-479.
- Long-term prognosis and management of hepatocellular carcinoma after curative treatment
- Naoshi Nishida
- Clin Mol Hepatol. 2020;26(4):480-483.
- Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
- Jaewhan Song
- Clin Mol Hepatol. 2020;26(4):484-486.
- Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?
- Nae-Yun Heo
- Clin Mol Hepatol. 2020;26(4):487-488.
- More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
- Paul Kwo, Deepti Dronamraju
- Clin Mol Hepatol. 2020;26(4):489-491.
- Original Articles The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma
- Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong
- Clin Mol Hepatol. 2020;26(4):492-505.
- Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
- Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee
- Clin Mol Hepatol. 2020;26(4):506-515.
- Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
- Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
- Clin Mol Hepatol. 2020;26(4):516-528.
- Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway
- Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
- Clin Mol Hepatol. 2020;26(4):529-539.
- Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
- Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong
- Clin Mol Hepatol. 2020;26(4):540-553.
- Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
- Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen
- Clin Mol Hepatol. 2020;26(4):554-561.
- Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
- Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
- Clin Mol Hepatol. 2020;26(4):562-576.
- Letters to the Editor Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
- Jeong Su Park, Soo Han Bae
- Clin Mol Hepatol. 2020;26(4):577-578.
- How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
- Bo Hyun Kim
- Clin Mol Hepatol. 2020;26(4):579-581.
- Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
- Dimitrios Patoulias, Michael Doumas
- Clin Mol Hepatol. 2020;26(4):582-583.
-
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC) The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC) - Dong Joon Kim, Won-Il Jeong, Hidekazu Tsukamoto, Bin Gao
- Clin Mol Hepatol. 2020;26(4):584-585.
- Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
- Seonghwan Hwang, Tianyi Ren, Bin Gao
- Clin Mol Hepatol. 2020;26(4):586-594.
- From intestinal dysbiosis to alcohol-associated liver disease
- Beatriz Garcia Mendes, Bernd Schnabl
- Clin Mol Hepatol. 2020;26(4):595-605.
- Autophagy and liver cancer
- Xiaojuan Chao, Hui Qian, Shaogui Wang, Sam Fulte, Wen-Xing Ding
- Clin Mol Hepatol. 2020;26(4):606-617.
- Programmed cell death in alcohol-associated liver disease
- Tatsunori Miyata, Laura E. Nagy
- Clin Mol Hepatol. 2020;26(4):618-625.
- Inter-professional and inter-departmental alcoholism rehabilitation program
- Masahiro Kikuchi, Naomi Matsutani, Ryota Ishihara, Masako Sugihara, Yuuki Mizuno, Chiyo Chiba, Takahiro Ohta, Eri Yamada, Sota Oguro, Yasuko Sato, Hiroki Bessho, Yoshinori Horie
- Clin Mol Hepatol. 2020;26(4):626-632.
- The lymphatic system in alcohol-associated liver disease
- Reiichiro Kondo, Yasuko Iwakiri
- Clin Mol Hepatol. 2020;26(4):633-638.
- Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
- Shiv Kumar Sarin, Shvetank Sharma
- Clin Mol Hepatol. 2020;26(4):639-651.
- Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies
- Seung Ha Park, Dong Joon Kim
- Clin Mol Hepatol. 2020;26(4):652-661.
- The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
- Jong Hwa Choi, Won Sohn, Yong Kyun Cho
- Clin Mol Hepatol. 2020;26(4):662-669.
- Liver-lung axes in alcohol-related liver disease
- Gavin E. Arteel
- Clin Mol Hepatol. 2020;26(4):670-676.
- Roles of the complement system in alcohol-induced liver disease
- Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He
- Clin Mol Hepatol. 2020;26(4):677-685.
- Emerging medical therapies for severe alcoholic hepatitis
- David Tornai, Gyongyi Szabo
- Clin Mol Hepatol. 2020;26(4):686-696.
- Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell
- Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong
- Clin Mol Hepatol. 2020;26(4):697-704.
- Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
- Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul
- Clin Mol Hepatol. 2020;26(4):705-714.
- Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
- Yun Seok Kim, Sang Geon Kim
- Clin Mol Hepatol. 2020;26(4):715-727.
- Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
- Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
- Clin Mol Hepatol. 2020;26(4):728-735.
- Alcohol and hepatocarcinogenesis
- Makiko Taniai
- Clin Mol Hepatol. 2020;26(4):736-741.
- Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
- Yuchen Liu, Xiaohui Wang, Yingzi Yang
- Clin Mol Hepatol. 2020;26(4):742-750.